Table of Contents
Chapter 1. Global Anti-radiation Drugs Market Executive Summary
1.1. Global Anti-radiation Drugs Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Compound
1.3.2. By Application
1.3.3. By Distribution Channel
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
Chapter 2. Global Anti-radiation Drugs Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer's Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Anti-radiation Drugs Market Dynamics
3.1. Market Drivers
3.1.1. Increase in Risk of Radiological and Nuclear Incidents
3.1.2. Rise in R&D of Radiopharmaceuticals
3.2. Market Challenges
3.2.1. High Cost of Drug Development
3.2.2. Regulatory Hurdles
3.3. Market Opportunities
3.3.1. Expansion in Emerging Markets
3.3.2. Investment in New Product Development
Chapter 4. Global Anti-radiation Drugs Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model
4.1.7. Porter's 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Anti-radiation Drugs Market Size & Forecasts by Compound 2022-2032
5.1. Segment Dashboard
5.2. Global Anti-radiation Drugs Market: Compound Revenue Trend Analysis, 2022 & 2032(USD Billion)
5.2.1. Potassium Iodide (KI)
5.2.2. Prussian Blue
5.2.3. DTPA (Diethylenetriamine Pentaacetate)
5.2.4. Others
Chapter 6. Global Anti-radiation Drugs Market Size & Forecasts by Application 2022-2032
6.1. Segment Dashboard
6.2. Global Anti-radiation Drugs Market: Application Revenue Trend Analysis, 2022 & 2032(USD Billion)
6.2.1. Acute Radiation Syndrome (ARS)
6.2.2. Cancer Treatment
6.2.3. Radiation Exposure
6.2.4. Others
Chapter 7. Global Anti-radiation Drugs Market Size & Forecasts by Distribution Channel 2022-2032
7.1. Segment Dashboard
7.2. Global Anti-radiation Drugs Market: Distribution Channel Revenue Trend Analysis, 2022 & 2032 (USD Billion)
7.2.1. Hospital Pharmacies
7.2.2. Retail Pharmacies
7.2.3. Others
Chapter 8. Global Anti-radiation Drugs Market Size & Forecasts by Region 2022-2032
8.1. North America Anti-radiation Drugs Market
8.1.1. U.S. Anti-radiation Drugs Market
8.1.1.1. Compound breakdown size & forecasts, 2022-2032
8.1.1.2. Application breakdown size & forecasts, 2022-2032
8.1.1.3. Distribution Channel breakdown size & forecasts, 2022-2032
8.1.2. Canada Anti-radiation Drugs Market
8.2. Europe Anti-radiation Drugs Market
8.2.1. Germany Anti-radiation Drugs Market
8.2.2. U.K. Anti-radiation Drugs Market
8.2.3. France Anti-radiation Drugs Market
8.2.4. Italy Anti-radiation Drugs Market
8.2.5. Rest of Europe Anti-radiation Drugs Market
8.3. Asia-Pacific Anti-radiation Drugs Market
8.3.1. China Anti-radiation Drugs Market
8.3.2. Japan Anti-radiation Drugs Market
8.3.3. India Anti-radiation Drugs Market
8.3.4. Rest of Asia-Pacific Anti-radiation Drugs Market
8.4. Latin America Anti-radiation Drugs Market
8.4.1. Brazil Anti-radiation Drugs Market
8.4.2. Mexico Anti-radiation Drugs Market
8.4.3 Rest of Latin America Anti-radiation Drugs Market
8.5. Middle East and Africa Anti-radiation Drugs Market
8.5.1. Saudi Arabia Anti-radiation Drugs Market
8.5.2. South Africa Anti-radiation Drugs Market
8.5.3. Rest of Latin America Anti-radiation Drugs Market
Chapter 9. Competitive Intelligence
9.1. Key Company SWOT Analysis
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. Amgen Inc.
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Market Strategies
9.3.2. Anbex Inc.
9.3.3. Arco Pharmaceuticals LLC
9.3.4. BTG International Inc.
9.3.5. Cellphire, Inc.
9.3.6. Chrysalis BioTherapeutics, Inc.
9.3.7. Darnitsa
9.3.8. Enzychem Lifesciences Corporation
9.3.9. Humanetics Corporation
9.3.10. Mission Pharmacal Company
9.3.11. Myelo Therapeutics GmbH
9.3.12. Partner Therapeutics
9.3.13. Pluri Inc.
9.3.14. Emergent BioSolutions Inc.
9.3.15. Jubilant Life Sciences
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes